Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Roffler

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 27, 2023
Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A reviewAdilet Beishenaliev, Yean Leng Loke, Sook Jing Goh, et al.
Journal of Virology|September 28, 2007
Identification of CD46 binding sites within the adenovirus serotype 35 fiber knobHongjie Wang, Yen-Chywan Liaw, Daniel Stone, et al.
Vaccine|June 2, 2009
In situ adenovirus vaccination engages T effector cells against cancerSebastian Tuve, Ying Liu, Khajornsak Tragoolpua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2012
Coadministration of epithelial junction opener JO-1 improves the efficacy and safety of chemotherapeutic drugsInes Beyer, Hua Cao, Jonas Persson, et al.
Pharmaceutics|December 28, 2019
Both IgM and IgG Antibodies Against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in MiceTien-Ching Chang, Bing-Mae Chen, Wen-Wei Lin, et al.
Human Gene Therapy|January 21, 2022
<i>In Vivo</i> Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy ReceptorHongjie Wang, Chang Li, Adebimpe O Obadan, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicinMaximilian Richter, Roma Yumul, Hongjie Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivoShih-Hsin Tu, Hsing-I Huang, Su-I Lin, et al.
Journal of Virology|August 30, 2008
In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46Hongjie Wang, Ying Liu, Zongyi Li, et al.
Scientific Reports|May 13, 2022
Translational development of a tumor junction opening technologyJiho Kim, Chang Li, Hongjie Wang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 27, 2023
Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A reviewAdilet Beishenaliev, Yean Leng Loke, Sook Jing Goh, et al.
Journal of Virology|September 28, 2007
Identification of CD46 binding sites within the adenovirus serotype 35 fiber knobHongjie Wang, Yen-Chywan Liaw, Daniel Stone, et al.
Vaccine|June 2, 2009
In situ adenovirus vaccination engages T effector cells against cancerSebastian Tuve, Ying Liu, Khajornsak Tragoolpua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2012
Coadministration of epithelial junction opener JO-1 improves the efficacy and safety of chemotherapeutic drugsInes Beyer, Hua Cao, Jonas Persson, et al.
Pharmaceutics|December 28, 2019
Both IgM and IgG Antibodies Against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in MiceTien-Ching Chang, Bing-Mae Chen, Wen-Wei Lin, et al.
Human Gene Therapy|January 21, 2022
<i>In Vivo</i> Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy ReceptorHongjie Wang, Chang Li, Adebimpe O Obadan, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicinMaximilian Richter, Roma Yumul, Hongjie Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivoShih-Hsin Tu, Hsing-I Huang, Su-I Lin, et al.
Journal of Virology|August 30, 2008
In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46Hongjie Wang, Ying Liu, Zongyi Li, et al.
Scientific Reports|May 13, 2022
Translational development of a tumor junction opening technologyJiho Kim, Chang Li, Hongjie Wang, et al.
Pageof 3